Publication | Closed Access

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder

Lipid DisorderPsychiatryCardiovascular DiseaseMood SymptomPharmacologyCardiovascular PharmacologyClinical TrialsDepressionDouble-blind Clinical TrialPharmacotherapyMood DisordersMental HealthBlood Lipid ValuesMedicineAdjuvant AtorvastatinDyslipidemia